Ulf Müller‐Ladner

1995–2025 年に発表

別表記
Ulf Müller-Ladner · Ulf Müller Ladner · Ulf Muller-Ladner · Ulf-Müller Ladner
180
論文数
36,618
被引用数
99
h 指数
174
i10 指数

被引用数

Ulf Müller‐Ladner の年別被引用数1982 年: 被引用 3 件1994 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 4 件1998 年: 被引用 10 件1999 年: 被引用 28 件2000 年: 被引用 41 件2001 年: 被引用 35 件2002 年: 被引用 46 件2003 年: 被引用 53 件2004 年: 被引用 62 件2005 年: 被引用 77 件2006 年: 被引用 86 件2007 年: 被引用 107 件2008 年: 被引用 130 件2009 年: 被引用 172 件2010 年: 被引用 155 件2011 年: 被引用 205 件2012 年: 被引用 204 件2013 年: 被引用 184 件2014 年: 被引用 232 件2015 年: 被引用 229 件2016 年: 被引用 248 件2017 年: 被引用 299 件2018 年: 被引用 223 件2019 年: 被引用 1,128 件2020 年: 被引用 1,286 件2021 年: 被引用 1,495 件2022 年: 被引用 1,284 件2023 年: 被引用 744 件2024 年: 被引用 1,178 件2025 年: 被引用 567 件2026 年: 被引用 9 件1983〜1993 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,161 件、この内訳の 14.9%イタリア: 引用元論文 1,108 件、この内訳の 7.6%イギリス: 引用元論文 1,075 件、この内訳の 7.4%ドイツ: 引用元論文 1,047 件、この内訳の 7.2%中国: 引用元論文 1,025 件、この内訳の 7.1%フランス: 引用元論文 775 件、この内訳の 5.4%オランダ: 引用元論文 539 件、この内訳の 3.7%スイス: 引用元論文 536 件、この内訳の 3.7%日本: 引用元論文 517 件、この内訳の 3.6%カナダ: 引用元論文 437 件、この内訳の 3%スペイン: 引用元論文 417 件、この内訳の 2.9%ベルギー: 引用元論文 336 件、この内訳の 2.3%
0%14.9%その他 31.2%

分野

  • Medicine77.5%
  • Biochemistry, Genetics and Molecular Biology11%
  • Immunology and Microbiology7.2%
  • Engineering0.8%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • その他2.1%

トピック

  • Systemic Sclerosis and Related Diseases9.6%
  • Rheumatoid Arthritis Research and Therapies8.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis4.2%
  • Systemic Lupus Erythematosus Research3.3%
  • Inflammatory Myopathies and Dermatomyositis3.1%
  • Autoimmune and Inflammatory Disorders Research2.4%
  • その他68.9%

共著者

全論文

検索で開く
  1. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 被引用: 3,406

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 被引用: 2,766

  3. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 被引用: 652

  4. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Szucs, Carlos Alberto von Mühlen, Valeria Riccieri, Srđan Novak, Carlo Chizzolini, Anna Kotulska, Christopher P. Denton, Paulo C Coelho, Ina Kötter, İsmail Şimşek, Paloma García de la Peña Lefebvre, É. Hachulla, James R. Seibold, Simona Rednic, Jiří Štork, Jadranka Morović‐Vergles, Ulrich A. Walker - Annals of the Rheumatic Diseases 2010 被引用: 1,428

  5. Mapping and predicting mortality from systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore - Annals of the Rheumatic Diseases 2017 被引用: 684

  6. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2023 被引用: 273

  7. Update of EULAR recommendations for the treatment of systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana ほか 35 名 - Annals of the Rheumatic Diseases 2016 被引用: 1,116

  8. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 669

  9. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 812

  10. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 被引用: 500

  11. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

    著者: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 被引用: 825

  12. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

    著者: , , , , , , , , , , , , , , , , , - Nature Medicine 2009 被引用: 705

  13. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    著者: , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 被引用: 364

  14. Predictors of progression in systemic sclerosis patients with interstitial lung disease

    著者: , , , , , , , , , , , , - European Respiratory Journal 2020 被引用: 239

  15. The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

    著者: , , , , , - Journal of Clinical Medicine 2021 被引用: 109

  16. Mutual regulation of metabolic processes and proinflammatory NF-κB signaling

    著者: , , - Journal of Allergy and Clinical Immunology 2020 被引用: 129

  17. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

    著者: , , , , , , , , - Annals of the Rheumatic Diseases 2007 被引用: 922

  18. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes

    著者: , , , , , , , , , , , - Arthritis Research & Therapy 2006 被引用: 235

  19. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriela Riemekasten, Simona Rednic, Edoardo Rosato, Marta Saracco, A Scheja, Vanessa Smith, Carina Mihai, Gabriela Szucs, Matija Tomšič, Gabriele Valentini, Ulrich A. Walker, R Westhovens, Şule Yavuz, Thierry Zénone - Annals of the Rheumatic Diseases 2014 被引用: 428

  20. Current Treatment Options for Osteoarthritis

    著者: , , - Current Rheumatology Reviews 2017 被引用: 235

  21. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis

    著者: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 被引用: 188

  22. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    著者: , , , , , , , , , , , , , , , , , - PLoS ONE 2016 被引用: 277

  23. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    著者: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 被引用: 438

  24. Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis

    著者: , , , , - Nature Clinical Practice Rheumatology 2005 被引用: 337